Stay updated on Pembrolizumab Reirradiation in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The NIH website-transition announcement banner is no longer displayed. The page still shows a 403 Forbidden error instead of the study record.
    Difference
    1%
    Check dated 2026-11-08T05:16:40.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer's displayed site revision changes from v3.7.2 to v3.8.0; the study record remains inaccessible with a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:10:58.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces updates and FAQs about a website transition, including that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-25T02:11:40.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T02:00:33.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:37:21.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates the study page is temporarily inaccessible.
    Difference
    22%
    Check dated 2026-09-20T01:33:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Reirradiation in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.